Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis

被引：63
|
作者：
van Manen, Mirjam J. G. [1 ]
Birring, Surinder S. [2 ]
Vancheri, Carlo [3 ]
Vindigni, Virginia
Renzoni, Elisabetta [4 ]
Russell, Anne-Marie [4 ,5 ]
Wapenaar, Monique [1 ]
Cottin, Vincent [6 ]
Wijsenbeek, Marlies S. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Dept Resp Med, Rotterdam, Netherlands
[2] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England
[3] Univ Catania, Dept Clin & Expt Med, Sect Resp Dis, Catania, Italy
[4] Royal Brampton Hosp, Interstitial Lung Dis Unit, London, England
[5] Imperial Coll London, Natl Heart & Lung Inst, London, England
[6] Claude Bernard Lyon 1 Univ, Hosp Civils Lyon, Louis Pradel Hosp, Dept Resp Med, Lyon, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷 / 04期
基金：
美国国家卫生研究院;
关键词：
QUESTIONNAIRE; VALIDATION; DISEASE; REFLEX; TRIAL; LUNG;
D O I：
10.1183/13993003.01157-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] THE PREDICTIVE FACTORS FOR THE EFFECT OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Ichimuray
    Tsushima, K.
    Matsumura, T.
    Yokota, A.
    Terada, J.
    Iesato, K.
    Sakao, S.
    Tada, Y.
    Tanabe, N.
    Tatsumi, K.
    RESPIROLOGY, 2014, 19 : 148 - 148
  • [22] Pirfenidone therapy for patients with progressive idiopathic pulmonary fibrosis
    Ihle, Franziska
    Veith, Tobias
    Gregor, Zimmermann
    Gabriela, Wypior
    Juergen, Behr
    Claus, Neurohr
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [23] CLINICAL EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Yamauchi, H.
    Bando, M.
    Sata, M.
    Nakasone, E.
    Mizushina, Y.
    Suzuki, E.
    Mato, N.
    Nakaya, T.
    Yamasawa, H.
    Sugiyama, Y.
    RESPIROLOGY, 2011, 16 : 318 - 319
  • [24] PHARMACOECONOMIC ANALISYS OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Kolbin, A.
    Kurylev, A.
    Balykina, Y.
    Proskurin, M.
    VALUE IN HEALTH, 2018, 21 : S412 - S412
  • [25] Our Experience with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Ozyurek, Berna Akinci
    Erdogan, Yurdanur
    Demirci, Nilgun Yilmaz
    Ozden, Sertac Buyukyaylaci
    Ozdemirel, Tugce Sahin
    EURASIAN JOURNAL OF PULMONOLOGY, 2016, 18 (01) : 61 - 62
  • [26] Pirfenidone should be prescribed for patients with idiopathic pulmonary fibrosis
    Jenkins, Gisli
    THORAX, 2013, 68 (07) : 603 - 605
  • [27] Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
    Iwata, Takekazu
    Yoshida, Shigetoshi
    Fujiwara, Taiki
    Wada, Hironobu
    Nakajima, Takahiro
    Suzuki, Hidemi
    Yoshino, Ichiro
    ANNALS OF THORACIC SURGERY, 2016, 102 (06): : 1905 - 1910
  • [28] Reply to: Comment on: CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
    不详
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (10) : 1990 - 1990
  • [29] Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
    Noble, Paul W.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    du Bois, Roland M.
    Fishman, Robert S.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Lederer, David
    Leff, Jonathan A.
    Nathan, Steven D.
    Pereira, Carlos A.
    Swigris, Jeffrey J.
    Valeyre, Dominique
    King, Talmadge E.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [30] Pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Xaubet, Antoni
    Serrano-Mollar, Anna
    Ancochea, Julio
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 275 - 281
12345